SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals (CRML) is trending following news of a potential U.S. government stake in the company to secure rare earth mineral supply chains. Community members are discussing the implications of this government interest, comparing it to similar situations with other companies, and anticipating a significant rise in share price. The focus remains on CRML's access to the Greenland rare earth mine and its potential to become a key player in the U.S. critical minerals sector.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as the community rallies around its strong IRL presence and continues building its ecosystem.  Enthusiastic community members are highlighting the increasing holder count and the numerous real-world products associated with the brand, creating a strong sense of long-term potential. The community's focus remains on building the brand and expanding its reach, signaling confidence in Kendu's future.

Ucore Rare Metals, Inc. Is a technology company, which engages in the business of metal separation products, and services to the mining and mineral extraction industry. Its projects include Bokan-Dotson Ridge Rare Earth Element. The company was founded on October 5, 2006 and is headquartered in Halifax, Canada.

Ucore Rare Metals Inc

Ucore Rare Metals Inc.

Ucore Rare Metals Inc. ($UURAF) is trending due to growing excitement around its strategic position in the rare earth element (REE) sector, particularly its focus on REE processing and refining rather than mining. Community members are discussing the company's proprietary RapidSX technology, government backing, and potential for significant growth as it progresses towards commercial production in Louisiana. Many believe $UURAF is undervalued, citing its potential role in securing a domestic REE supply chain and reducing reliance on China.

Proof Of Liquidity

Polygon's POL is trending as the community discusses its zkEVM scaling narrative and the recent Katana private mainnet launch, which includes a $KAT token airdrop for POL stakers. Partnerships with major companies like Adobe and Flipkart are being cited as further validation for the project. Some users are pointing to the MATIC/BTC chart as a sign of strength for POL.

eCash (XEC) is a Layer-1 digital cash network, developed by Bitcoin ABC. It was created on Nov 15th, 2020, and has since distinguished itself from its predecessors and other Bitcoin clients by integrating the breakthrough Avalanche consensus with its core proof-of-work (PoW) layer, extending its security and fundamental capabilities.  This hybrid consensus integration gives it unique properties for a Bitcoin-like chain, such as interoperability, staking rewards, real-time processing, and an improved overall extensibility, which is hard to achieve in a completely trustless manner using only Nakamoto consensus.  The development roadmap is set with three main goals: Scaling transaction throughput from ~100 tps to more than 5.000.000 tps Improving the payment experience with a less than 3 second transaction finality time Extending the protocol and establishing fork-free upgrade routines, allowing for more rapid, iterative development

eCash

eCash is trending as the Electronic Cash Conference 2025 approaches, with the community buzzing about the upcoming keynotes and presentations focused on network efficiency, scalability, and Bitcoin script applications. Recent developments like NOWNodes adding eCash transaction tracking and new listings on Houdini Swap are also generating interest. The community is also excited about the local eCash v1.5.0 release, staking rewards, and the recent Bitcoin ABC maintenance release.

Themes ETF Trust - Themes Humanoid Robotics ETF

Themes ETF Trust - Themes Robotics & Automation ETF

BOTT is trending as the robotics and automation sector gains attention, particularly around humanoid robots and AI applications. Community members are evaluating ETFs with exposure to Chinese robotics companies, sparked by news of a potential Unitree Robotics IPO. Discussions also highlight the fund's performance relative to broader market benchmarks and other thematic ETFs.

ARK Investment Management LLC - ARK Autonomous Technology & Robotics ETF

ARK Autonomous Technology & Robotics ETF

Recent discussion around ARKQ highlights its resilience and potential for growth, especially given the increasing real-world applications of robotics and AI.  Community members point out its strong performance relative to other ARK funds and QQQ, sparking interest in humanoid robotics and agentic AI.  The ETF is also being discussed in relation to government contracts, space economy developments, and potential impacts from investigations into robotics imports.

KraneShares Trust - KraneShares Global Humanoid and Embodied Intelligence Index ETF

KraneShares Global Humanoid and Embodied Intelligence Index ETF

KOID is trending as investors discuss the increasing use of robots and humanoids, especially in China. The community is also following Unitree Robotics' potential IPO and the Chinese government's significant investment in the humanoid robotics sector. Some are comparing KOID to other robotics ETFs and noting its exposure to Chinese companies, while others highlight promotional activity involving robots in public.

Toilet Dust ($TOILET) is a meme coin created on the Sui blockchain, designed to add some humor and chaos to the crypto world while playing a key role in driving the growth and adoption of the Sui ecosystem. Unlike typical meme coins that focus solely on entertainment or speculation, $TOILET’s mission goes beyond just the jokes. It is committed to fostering a vibrant, active community that’s passionate about both crypto and fun, while encouraging new users to explore the Sui blockchain.  The project’s foundation is built on the idea that a thriving network benefits everyone—whether you're a crypto enthusiast, developer, or investor. By embracing the lighthearted and unpredictable nature of meme coins, $TOILET brings attention to the Sui ecosystem and attracts a diverse range of participants. As $TOILET grows, so does the network and its ecosystem, creating more opportunities for everyone involved.  In addition to just memes, $TOILET is actively working on expanding its presence across social media, building partnerships, and increasing its visibility in the crypto space. It’s about creating an inclusive environment where the community drives the project forward. So, whether you're in it for the laughs, the community, or the chance to be part of something new, Toilet Dust is here to make a splash—join the movement or get left behind!

Toilet Dust

Toilet Crypto ($TOILET) is trending amid community excitement surrounding its association with the SUI ecosystem and anticipation for upcoming catalysts, including a PFP collection mint and potential partnerships. Community members are actively discussing accumulation strategies and expressing bullish sentiment, while also addressing concerns about market volatility and past price action. Some users highlight the doxxed team and potential for significant growth, emphasizing $TOILET's position as an OG memecoin on SUI.

Gremly

Gremly Crypto is trending as the community draws comparisons to other meme coins like Pepe and Shiba Inu, with some highlighting the potential for significant gains. Conversations revolve around its chart patterns and community promotion efforts, as well as mentions of the contract address. The crypto is also being discussed alongside other trending tokens like UpDog.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock?

Nurix Therapeutics (NRIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Misses Revenue Estimates

EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of -26.87% and -32.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of +15.38% and +9.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

EyePoint Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Latest Ratings for EYPT
 DateFirmActionFromTo Nov 2021HC Wainwright & Co.MaintainsBuy May 2021HC Wainwright & Co.MaintainsBuy Jan 2021Cantor FitzgeraldInitiates Coverage OnOverweight
 View More...

Shares of 4D Molecular Therapeutics Inc. (FDMT) plummeted over 35% to $17.30 by Wednesday afternoon, marking it as the top loser among U.S. stocks. Surprisingly, retail traders remain highly bullish on the stock, with Stocktwits sentiment extremely bullish (85/100) amid extremely high message volumes (95/100).<figure class="image"><img style="aspect-ratio:1308/308;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FDMT_Sentiment_Meter_On_Jul_17_5f2f85024d.png" alt="FDMT Stocktwits Sentiment Meter On Jul 17" width="1308" height="308"><figcaption>FDMT Stocktwits Sentiment Meter On Jul 17</figcaption></figure>Initially, FDMT shares climbed following the release of encouraging mid-stage clinical study results for its 4D-150 gene therapy, aimed at treating wet age-related macular degeneration (wAMD), a chronic eye disorder that leads to blurred vision or blind spots in central vision.However, the broader market turned its focus to various downside risks, including safety concerns raised by RBC Capital. While the firm maintains 4D-150 is "best in class," it flagged a "safety blip" – one case of inflammation in a patient with a history of syphilis, Investing.com <a href="https://in.investing.com/news/stock-market-news/4d-molecular-therapeutics-tumbles-following-midstage-clinical-study-results-432SI-4316187">reported</a>. BMO Capital lowering the price target further may have added to the pressure.Despite the sell-off, retail investors on Stocktwits seem to view Wednesday’s crash as a buying opportunity. One user noted that 4D’s peers, Ocular Therapeutix Inc. (OCUL), Adverum Biotechnologies Inc (ADVM) and EyePoint Pharmaceuticals Inc. (EYPT), “are taking it on the chin today.”“Obviously, Nasdaq taking it hard today as well. &nbsp;Perhaps, just a general opinion of overvaluation and market fatigue? &nbsp;Very odd stock movement to me, I do expect it will reverse soon,” said Stocktwits user ‘<a href="https://stocktwits.com/ehschunk/message/579821570">ehschunk</a>’.<figure class="image"><img style="aspect-ratio:1318/454;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FDMT_stocktwits_comment_Jul_17_88b7f49b68.png" alt="Stocktwits user ehschunk's post on FDMT stream" width="1318" height="454"><figcaption>Stocktwits user ehschunk's post on FDMT stream</figcaption></figure>The overall market sentiment didn’t help, as U.S. stocks pulled back from their all-time highs on Wednesday, impacted by falling chip and tech stocks, though the Dow Jones managed its sixth consecutive day of gains.FDMT shares are down over 19% year-to-date, contrasting with OCUL’s impressive 65% rise. EYPT has had an even tougher year, losing 57% so far, while ADVM has lost only 0.18%.However, FDMT’s consistent performance in beating EPS estimates for the past four quarters provides some relief and hope for a rebound among its retail investors.

Wall Street’s Top Loser Today Stays In Retail’s Good Books: Stocktwits Extremely Bullish On FDMT

Despite a 35% drop in shares, retail investors remain bullish on 4D Molecular Therapeutics

Wall Street’s Top Loser Today Remains In Retail’s Good Books

Equity

Despite a 35% drop in shares, retail investors remain bullish on 4D Molecular Therapeutics on promising clinical study results

Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile.
read more...

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

- Charles Wykoff, M.D., Ph.D. joins Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board - Usha Chakravarthy, M.B.B.S, PhD., Allen Ho, M.D. FACS FASRS and Frank Holz, M.D., F.E.B.O...

EyePoint Pharmaceuticals (EYPT, $20.27) RSI Indicator left the oversold zone on April 01, 2024

This is a signal that EYPT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

EyePoint Pharmaceuticals (EYPT, $20.27) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that EYPT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Pharmaceuticals Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

EYPT
EyePoint Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest EYPT News

EYPT EyePoint Pharmaceuticals Inc